EVALUATION OF DIBEKACIN SULFATE IN THE TREATMENT OF UPPER URINARY TRACT INFECTIONS --A CLINICAL STUDY OF INTRAVENOUS ADMINISTRATION--

IR (HANDLE) Web Site Open Access

Bibliographic Information

Other Title
  • 上部尿路感染症に対する硫酸ジベカシン(DKB)の使用経験 -点滴静注法の臨床的検討-
  • ジョウブ ニョウロ カンセンショウ ニ タイスル リュウサン ジベカシン DK

Search this article

Description

Of 15 cases with upper urinary tract infections admitted to our hospital, dibekacin sulfate (DKB) was administered in the dosage of 50 mg twice daily for a period from 5 to 12 days intravenously. The results obtained were as follows: 1) Clinical results were excellent in 4 cases, good in 6 cases, poor in 3 cases and ineffective in 2 cases, and the efficacy was 66.7%. 2) No remarkable side effects were observed except a case whose serum creatinine rose slightly for a time.

Journal

  • Hinyokika Kiyo

    Hinyokika Kiyo 25 (11), 1205-1209, 1979-11

    京都大学医学部泌尿器科学教室

Details 詳細情報について

Report a problem

Back to top